STOCK TITAN

Elizabeth Reed plans sale of 2,994 TVTX shares (NASDAQ: TVTX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Elizabeth Reed filed a Rule 144 notice to sell 2,994 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/04/2026 on NASDAQ, with an aggregate market value of 96,360.09.

The filing also lists prior sales during the past three months: 7,175 shares of common stock sold on 02/03/2026 for gross proceeds of 230,463.88, and 10,000 shares sold on 01/20/2026 for gross proceeds of 273,420.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing mean for TVTX shareholders?

This Form 144 shows Elizabeth Reed plans to sell 2,994 TVTX common shares under Rule 144. It also discloses two recent sales totaling 17,175 shares, giving investors transparency into her recent trading activity in TVTX stock.

How many TVTX shares is Elizabeth Reed planning to sell under this notice?

The notice states that 2,994 shares of TVTX common stock are to be sold. These shares are to be sold via Morgan Stanley Smith Barney LLC’s Executive Financial Services platform on NASDAQ, with an aggregate market value of 96,360.09.

What recent TVTX stock sales by Elizabeth Reed are disclosed in this Form 144?

The filing lists two recent sales of TVTX common stock: 7,175 shares sold on 02/03/2026 for 230,463.88 and 10,000 shares sold on 01/20/2026 for 273,420.00, providing a three‑month trading history.

At what firm and exchange will Elizabeth Reed’s planned TVTX share sale occur?

The document shows the planned sale of 2,994 TVTX shares will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are expected to be sold on the NASDAQ stock market on or about 02/04/2026.

How were the 2,994 TVTX shares to be sold by Elizabeth Reed acquired?

According to the filing, the 2,994 TVTX common shares were acquired as restricted stock from the issuer on 01/31/2026. The nature of payment is listed as “Not Applicable,” indicating no separate cash purchase price at acquisition.

What is the purpose of Rule 144 in the context of this TVTX filing?

In this case, Rule 144 provides a framework for Elizabeth Reed to resell restricted TVTX shares. The rule requires disclosure of planned sales, prior three‑month sales, acquisition details, and broker information to promote transparency around insider and affiliate stock sales.
Travere Therapeutics Inc

NASDAQ:TVTX

TVTX Rankings

TVTX Latest News

TVTX Latest SEC Filings

TVTX Stock Data

2.94B
82.79M
0.75%
117.25%
13.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO